INVESTOR WEBINAR

How NextGen Scientific is Rewriting the Biotech Business Model

✦ $300 million previous exit by founders.

✦ Dual revenue streams from oncology and supplements.

✦ $75M+ raised with third-party market valuation.

✦ Patents secured through 2038.

As part of our in-depth investor webinar series, we'll be going live on May 7th at 11am PST to cover the accredited opportunity you don't want to miss. Join the conversation as we discuss the unbound market potential of our life-saving drugs.

Already signed up?

Visit our INVESTOR WEBSITE